Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Drugmaker MannKind Chooses Lone Wolf Strategy
Drugmaker MannKind Chooses Lone Wolf Strategy
Drugmaker MannKind Chooses Lone Wolf Strategy
Submitted by
admin
on October 8, 2009 - 11:35am
Source:
ethioPlanet
News Tags:
MannKind
diabetes
inhaled insulin
Afresa
Headline:
Drugmaker MannKind Chooses Lone Wolf Strategy
Do Not Allow Advertisers to Use My Personal information
